GALLANT 5 Tesaglitazar Versus Metformin

PHASE3TerminatedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GALIDA

Trial Locations (130)

Unknown

Research Site, Birmingham

Research Site, Columbiana

Research Site, Mobile

Research Site, Carlisle

Research Center, Sherwood

Research Site, Chula Vista

Research Site, Escondido

Research Site, Huntington Beach

Research Site, Los Angeles

Research Site, Mission Viejo

Research Site, Orange

Research Site, Pasadena

Research Site, Pomona

Research Site, Redondo Beach

Research Site, Sacramento

Research Site, Colorado Springs

Research Site, Wheat Ridge

Research Site, Clearwater

Research Site, Gainesville

Research Site, Hollywood

Research Site, Jacksonville

Research Site, Miami

Research Site, West Palm Beach

Research Site, Atlanta

Research Site, Brunswick

Research Site, Carollton

Research Site, Honolulu

Research Site, Boise

Research Site, Evansville

Research Site, Kansas City

Research Site, Overland Park

Research Site, Witchita

Research Site, Bossier City

Research Site, New Orleans

Research Site, Baltimore

Research Site, Kalamazoo

Research Site, Las Vegas

Research Site, Hamilton

Research Site, Albuquerque

Research Site, Albany

Research Site, New York

Research Site, Pahrump

Research Site, Rochester

Research Site, The Bronx

Research Site, White Plains

Research Site, Charlotte

Research Site, Cincinnati

Research Site, Dayton

Research Site, Kettering

Research Site, Oklahoma City

Research Site, Medford

Research Site, Philadelphia

Research Site, Simpsonville

Research Site, Morristown

Research Site, Corpus Christi

Research Site, Dallas

Research Site, Lubbock

Research Site, San Antonio

Research Site, Burke

Research Site, Norfolk

Research Site, Richmond

Research Site, Tacoma

Research Site, Menomonee Falls

Research Site, Milwaukee

Research Site, Hämeenlinna

Research Site, Helsinki

Research Site, Joensuu

Research Site, Kouvola

Research Site, Kuopio

Research Site, Mikkeli

Research Site, Oulu

Research Site, Salo

Research Site, Tampere

Research Site, Vantaa

Research Site, Aschaffenburg

Research Site, Bad Segeberg

Research Site, Beckum

Research Site, Berlin

Research Site, Dresden

Research Site, Ehrenberg

Research Site, Essen

Research Site, Feldafing

Research Site, Hamburg

Research Site, Hanover

Research Site, Hermaringen

Research Site, Künzing

Research Site, Langen

Research Site, Mannheim

Research Site, Marl

Research Site, Nuremberg

Research Site, Pirna

Research Site, Rotenburg/Fulda

Research Site, Ashkelon

Research Site, Haifa

Research Site, Holon

Research Site, Jerusalem

Research Site, Rishon LeZiyyon

Research Site, Safed

Research Site, Tel Aviv

Research Site, Beek en Donk

Research Site, Bennebroe

Research Site, Deurne

Research Site, Huizen

Research Site, Losser

Research Site, Nijverdal

Research Site, Rijswijk

Research Site, Roelofarendsveen

Research Site, Rotterdam

Research Site, The Hague

Research Site, Bergen

Research Site, Oslo

Research Site, Østerås

Research Site, San Vicente de Raspeig

Research Site, Villar del Arzobispo

Research Site, Alzira (Valencia)

Research Site, Barcelona

Research Site, Begonte (Lugo)

Research Site, Madrid

Research Site, Seville

Research Site, Aberdeen

Research Site, Ayr

Research Site, Bath

Research Site, Berks

Research Site, Bucks

Research Site, Coventry

Research Site, Dundee

Research Site, Glasgow

Research Site, Manchester

Research Sites, Northampton

Research Site, Wiltshire

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY